• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov11
Celldex Therap released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 0 (forecast USD 1.084 M), actual EPS USD -1.0093 (forecast USD -0.9063)
04:00
Celldex Therap released FY2025 9 Months earnings on November 10, 2025 (EST), actual revenue USD 1.425 M, actual EPS USD -2.6729
04:00
Aug8
Celldex Therap released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 730K (forecast USD 1.132M), actual EPS USD -0.8525 (forecast USD -0.8663)
03:00
Celldex Therap released FY2025 Semi-Annual earnings on August 7 (EST), actual revenue USD 1.424 M (forecast USD 2.75 M), actual EPS USD -1.6628 (forecast USD -1.48)
03:00
Jun14
Cedars Medical Presents Phase II Study Data on Chronic Spontaneous Urticaria Drug
14:51
Jun10
Sedaris Medical to Present Bazolovi Monoclonal Antibody Phase II Data at EAACI
20:02

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -67.04 M, EPS -1.0093

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 730 K, Net Income -56.6 M, EPS -0.8525

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 695 K, Net Income -53.8 M, EPS -0.8103

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MGRT
13.050
+143.93%
+7.700
PCSA
6.680
+122.30%
+3.675
YCBD
2.270
+58.74%
+0.840
ATPC
0.1408
+56.44%
+0.051
VYNE
0.6000
+48.99%
+0.197
ANDG
23.500
+46.88%
+7.500
ISPO
4.170
+46.83%
+1.330
MDLN
41.000
+41.38%
+12.000
CGTL
1.250
+31.30%
+0.298
GLIBR
8.490
+29.03%
+1.910
View More